Search research articles
Contact Us
Filters
Showing results (1-10 of 5) with videos related to
Page
of 1
Sort By:
Bioinformatics (Oxford, England)
|
May 30, 2013
A method for finding consensus breakpoints in the cancer genome from copy number data
Laura Toloşi, Jessica Theißen, Konstantin Halachev, et al.
BMC Cancer
|
November 20, 2014
FOXP1 inhibits cell growth and attenuates tumorigenicity of neuroblastoma
Sandra Ackermann, Hayriye Kocak, Barbara Hero, et al.
Human Molecular Genetics
|
January 25, 2013
Low p14ARF expression in neuroblastoma cells is associated with repressed histone mark status, and enforced expression induces growth arrest and apoptosis
Daniel Dreidax, Sina Gogolin, Christina Schroeder, et al.
Nature
|
July 8, 2016
Multiple mechanisms disrupt the let-7 microRNA family in neuroblastoma
John T Powers, Kaloyan M Tsanov, Daniel S Pearson, et al.
Cancer Discovery
|
August 7, 2025
Extrachromosomal DNA-Driven Oncogene Dosage Heterogeneity Promotes Rapid Adaptation to Therapy in MYCN-Amplified Cancers
Giulia Montuori, Fengyu Tu, Di Qin, et al.
Page
of 1
Search research articles
Search
Showing results (1-10 of 5) with videos related to
Sort By:
Page
of 1
Bioinformatics (Oxford, England)
|
May 30, 2013
A method for finding consensus breakpoints in the cancer genome from copy number data
Laura Toloşi, Jessica Theißen, Konstantin Halachev, et al.
BMC Cancer
|
November 20, 2014
FOXP1 inhibits cell growth and attenuates tumorigenicity of neuroblastoma
Sandra Ackermann, Hayriye Kocak, Barbara Hero, et al.
Human Molecular Genetics
|
January 25, 2013
Low p14ARF expression in neuroblastoma cells is associated with repressed histone mark status, and enforced expression induces growth arrest and apoptosis
Daniel Dreidax, Sina Gogolin, Christina Schroeder, et al.
Nature
|
July 8, 2016
Multiple mechanisms disrupt the let-7 microRNA family in neuroblastoma
John T Powers, Kaloyan M Tsanov, Daniel S Pearson, et al.
Cancer Discovery
|
August 7, 2025
Extrachromosomal DNA-Driven Oncogene Dosage Heterogeneity Promotes Rapid Adaptation to Therapy in MYCN-Amplified Cancers
Giulia Montuori, Fengyu Tu, Di Qin, et al.
Page
of 1